
Ohki Healthcare Holdings Co.,Ltd.
3417.TJPXHealthcareMedical - Pharmaceuticals
Latest quote
¥1,055
¥0.00 · 0.00%
3417.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteOhki Healthcare Holdings Co.,Ltd., a venerable Japanese enterprise founded in Tokyo in 1658, operates with a broad and diversified portfolio across numerous sectors. The company primarily engages in the import, export, distribution, and sale of an extensive range of products. Its vast offerings encompass pharmaceuticals, over-the-counter drugs, medical devices, veterinary medicines, health foods, and cosmetics, alongside a wide array of daily necessities. The company also handles specialized items such as poisons and deleterious substances, reagents, measuring instruments, optical instruments, electrical products, and communication equipment. Additionally, Ohki Healthcare Holdings supplies a comprehensive selection of consumer goods, including dairy products, pet supplies, textiles, sanitary items, beauty and health equipment, sports and leisure gear, nursing care products, toys, stationery, household goods, groceries, food additives, alcoholic beverages, grains, salt, and tobacco. Its reach extends to agricultural and industrial markets, providing chemicals, fertilizers, pesticides, gardening essentials, and other agricultural supplies. Beyond its significant trading operations, the company is actively involved in manufacturing various products, including pharmaceuticals, quasi-drugs, cosmetics, health foods, killing agents, medical and sanitary items, medical skin care products, soft drinks, environmental conservation products, and diverse general merchandise. Furthermore, Ohki Healthcare Holdings offers a suite of services such as warehousing, the development and management of information processing systems, distribution system equipment, and software development. The company also manages retail pharmacies and drug stores, provides medical prescription dispensing services, operates in the nursing care sector, and facilitates license application agency services.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Hideo Matsui
- Listed since
- Jan 4, 2000
- Employees
- 685
Market position
Day range
Current ¥1,055
52-week range
Current ¥1,055
- Open
- ¥1,045
- Previous close
- ¥1,055
- Volume
- 15.5K
- 1.4× average
- Average volume
- 11.1K
- Average daily volume
- Market cap
- 14.39B JPY
- Beta
- 0.45
- Market reference 1
- 50-day average
- ¥1,106.92
- -4.69% below average
- 200-day average
- ¥1,290.86
- -18.27% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 31.57B JPY
- P/E (TTM)
- 19.22×
- P/B (TTM)
- 0.43×
- P/S (TTM)
- 0.04×
- EV / EBITDA
- 26.98×
- Earnings yield
- 7.37%
- Free cash flow yield
- -15.07%
- Dividend yield
- 2.84%
Profitability & efficiency
- Gross margin
- 4.73%
- Operating margin
- -0.03%
- Net margin
- 0.21%
- Return on equity
- 3.92%
- Return on assets
- 0.90%
- Return on invested capital
- 0.77%
Financial health
- Debt / equity
- 0.63×
- Current ratio
- 1.14×
- Altman Z-score
- 2.73
- Piotroski F-score
- 4 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 360.36B JPY | 349.45B JPY | 334.66B JPY | 304.45B JPY | 278.16B JPY |
| Cost of goods sold | 343.12B JPY | 331.26B JPY | 317.77B JPY | 288.87B JPY | 264.74B JPY |
| Gross profit | 17.24B JPY | 18.19B JPY | 16.89B JPY | 15.58B JPY | 13.42B JPY |
| Research and development | — | 19M JPY | 24M JPY | 24M JPY | 42M JPY |
| Selling, general, and administrative | 16.52B JPY | 15.4B JPY | 14.82B JPY | 13.49B JPY | 12.75B JPY |
| Operating expenses | 16.52B JPY | 15.42B JPY | 14.85B JPY | 13.52B JPY | 12.82B JPY |
| Interest income | 27M JPY | 27M JPY | 31M JPY | 25M JPY | 22M JPY |
| Interest expense | 145M JPY | 71M JPY | 35M JPY | 33M JPY | 36M JPY |
| Depreciation and amortization | 450M JPY | 387M JPY | 377M JPY | 375M JPY | 381M JPY |
| Operating income | 720M JPY | 2.77B JPY | 2.04B JPY | 2.06B JPY | 600M JPY |
| Net income | 1.34B JPY | 2.64B JPY | 2.21B JPY | 2.18B JPY | 971M JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 0.41
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
3417.T peers
ETFs holding 3417.T
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research 3417.Tresearch.disclaimer






